Edwards Acumen IQ hypotension prediction software
(Image courtesy of Edwards Lifesciences)

Edwards Lifesciences (NYSE:EW) has announced that its Acumen hypotension prediction index (HPI) software has received FDA 510(k) clearance.

Using data obtained from the Acumen IQ finger cuff, the software uses machine learning to alert clinicians of the likelihood a patient is trending toward hypotension, or low blood pressure. Until now, Acumen HPI software has only been available for patients using an invasive arterial line, according to Irvine, Calif.-based Edwards.

Get the full story on our sister site, Medical Design & Outsourcing.